#Cannabis
Stock News: CanniMed Therapeutics Inc. (TSX: CMED) Reports Financial Results
for Q2 2017
SASKATOON, Saskatchewan - June
12, 2017 (Investorideas.com Newswire) CanniMed Therapeutics Inc. (TSX: CMED)
("CanniMed" or the "Company") today released its financial
results for the three and six months ended April 30, 2017.
CanniMed's strong sales momentum
continued in the second quarter. Demand for oils has accounted for
progressively more of the Company's production, and CanniMed's recently
announced oils processing facility is designed to accommodate foreseen growth
of this key product group. Recent export sales for pharmacy distribution,
together with the Company's arrangements with PharmaChoice and discussions with
other Canadian pharmacy chains provide clear indications of future market
channels for medical cannabis, and CanniMed is focussed on this expected
evolution.
Marijuana /
Hemp Stocks
Like Marijuana
Stocks? View our Marijuana / Hemp
Stocks Directory
Join our Group
on Linkedin - Marijuana / Hemp
Stocks - News and Trends in Green Investing
Global Cannabis Investing - features Investor Ideas Cannabis
news
Get News Alerts on
Marijuana Stocks
Watch the 420 Cannabis Investor video
More Info:
This
news is published on the Investorideas.com Newswire - a global digital news
source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third
party sourced news, articles and equity research as well as creates original
content, including video, interviews and articles. Original content created by
investorideas is protected by copyright laws other than syndication rights. Our
site does not make recommendations for purchases or sale of stocks, services or
products. Nothing on our sites should be construed as an offer or solicitation
to buy or sell products or securities. All investment involves risk and
possible loss of investment. This site is currently compensated for news
publication and distribution, social media and marketing, content creation and
more. Contact each company directly regarding content and press release
questions. Disclosure is posted for each compensated news release, content
published /created if required but otherwise the news was not compensated for
and was published for the sole interest of our readers and followers. More
disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional
info regarding BC Residents and global Investors: Effective September 15 2008 -
all BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
No comments:
Post a Comment